Staci Rice experienced significant weight loss using the drug semaglutide, shedding 64 pounds in eight months. However, the cost of the medication prompted her to seek additional income through a side hustle in digital marketing. After stopping the expensive compounded version of semaglutide, she regained 26 pounds. Despite price reductions in the GLP-1 market, Rice's insurance did not cover weight-loss treatments, underscoring the financial challenges many face in accessing these potentially life-changing medications. The article also discusses proposed Medicare and Medicaid coverage changes for GLP-1 drugs.
The article highlights Staci Rice's journey of weight loss and financial challenges associated with the cost of semaglutide, prompting her to start a side hustle.
Rice relied on a compounded form of semaglutide to lose 64 pounds, but was forced to stop due to the drug's expense and subsequently gained back 26 pounds.
With insurance not covering semaglutide for weight loss, Rice's financial strain led her to seek additional income through a side hustle in digital marketing.
The competitive pricing in the GLP-1 market reflects ongoing efforts to improve affordability, yet many still face challenges accessing these medications.
Collection
[
|
...
]